Showing results (11-20 of 89) with videos related to
Sort By:
Pageof 9
Blood|April 1, 1991
Mutation of the p53 gene in human acute myelogenous leukemiaJ M Slingerland, M D Minden, S BenchimolThe EMBO Journal|March 1, 1993
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocationJ M Slingerland, J R Jenkins, S BenchimolClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2010
p27: a barometer of signaling deregulation and potential predictor of response to targeted therapiesSeth A Wander, Dekuang Zhao, Joyce M SlingerlandOncogene|June 18, 2013
ERα, SKP2 and E2F-1 form a feed forward loop driving late ERα targets and G1 cell cycle progressionW Zhou, S Srinivasan, Z Nawaz, et al.STAR Protocols|December 30, 2020
Obtaining Human Breast Adipose Cells for Breast Cancer Cell Co-culture StudiesManuel Picon-Ruiz, Juan A Marchal, Joyce M SlingerlandCancer Research|April 29, 2020
p27 as a Transcriptional Regulator: New Roles in Development and CancerSeyedeh Fatemeh Razavipour, Kuzhuvelil B Harikumar, Joyce M SlingerlandCell Cycle (Georgetown, Tex.)|October 16, 2009
p27 as Jekyll and Hyde: regulation of cell cycle and cell motilityMichelle D Larrea, Seth A Wander, Joyce M SlingerlandThe Journal of Clinical Investigation|April 15, 2011
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategySeth A Wander, Bryan T Hennessy, Joyce M SlingerlandThe Journal of Biological Chemistry|August 31, 2002
Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrestJeffrey C H Donovan, Jeffrey M Rothenstein, Joyce M SlingerlandCancer Research|March 4, 1998
Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epitheliumW Zhang, L R Kapusta, J M Slingerland, et al.Pageof 9